ICCM (Icecure Medical) Tariff Resilience Score: 5/10 (As of Jul. 01, 2026)


ICCM Icecure Medical Ltd ICCM
46 GF Score
Price $5.22
GF Value $21.33
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Icecure Medical Tariff Resilience Score?

Icecure Medical ICCM +8.64% 46 Tariff Resilience Score is 5 as of Jul. 01, 2026. GuruFocus rates ICCM with a GF Score™ of 46/100 and a GF Value™ of $21.33 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Icecure Medical ranks better than 79.12% on this metric.

Icecure Medical has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Icecure Medical has Icecure Medical Ltd imports key components and exports products globally, exposing it to tariff risks. It has been impacted by previous tariffs but is working on diversifying suppliers and markets. Industry-specific exemptions may offer some relief.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Icecure Medical might have Average Resilient.

Icecure Medical  (NAS:ICCM) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Icecure Medical Tariff Resilience Score Related Terms

ICCM vs LFWD, IRIX, GTHP: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Icecure Medical's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Icecure Medical Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Icecure Medical's Tariff Resilience Score falls into.


ICCM
46GF Score
Icecure Medical Ltd ICCM
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Icecure Medical (ICCM) has a Tariff Resilience Score of 5 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Icecure Medical ranks #175 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 20.9%.
Is Icecure Medical's Tariff Resilience Score too high?
Icecure Medical's current Tariff Resilience Score is 5. Based on the distribution chart, Icecure Medical ranks #175 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Icecure Medical has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Icecure Medical's Tariff Resilience Score compare to LFWD and IRIX?
According to the Medical Devices & Instruments industry distribution chart, Icecure Medical ranks #175 out of 838 companies for Tariff Resilience Score. This places Icecure Medical in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Icecure Medical's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icecure Medical stock overvalued right now?
Based on GuruFocus' analysis, Icecure Medical (ICCM) is currently considered Possible Value Trap. The stock's GF Value™ is $21.33, compared to a current price of $5.22 — trading 75.6% below its estimated fair value. The current Tariff Resilience Score is 5. Icecure Medical's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Icecure Medical (ICCM), the current Tariff Resilience Score is 5 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Icecure Medical (ICCM) Overvalued in 2026?

Based on GuruFocus' analysis, Icecure Medical stock appears to be undervalued. The current stock price of $5.22 is trading 75.6% below its estimated GF Value™ of $21.33. GuruFocus considers Icecure Medical to be Possible Value Trap.

Key valuation signals for ICCM:

  • Tariff Resilience Score: 5
  • GF Value™: $21.33 vs. price of $5.22 (75.6% below fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the ICCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Icecure Medical Business Description

Address 7 Haeshel Street, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
46GF Score

Get the complete analysis for ICCM

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.22
Price
$21.33
GF Value